| Model Number |
H7493941838220 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969)
|
| Date of Event |
05/21/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
It was reported that patient complications occurred.The patient was on gpiib/iiia inhibitors and on prior regimen of aspirin (>= 72 hours) and antiplatelet other than aspirin (>= 72 hours) at the time of the procedure.A loading dose of 300mg of clopidogrel was given prior to the procedure.The 40 mm x 2.00 mm target lesion was located in the first obtuse marginal branch of the left circumflex artery (lcx) and was pre-treated with a 2.00 mm x 30 mm semi-compliant balloon angioplasty catheter resulting in 0% residual stenosis and timi flow 3.The target lesion was then successfully treated with a 2.25 mm x 38 mm synergy xd drug eluting stent resulting in 0% residual stenosis and timi flow of 3.A non-target lesion extending from the distal left anterior descending artery (lad) to the mid lad was successfully treated prior to the treatment of target lesion using a 2.25 mm x 38 mm drug eluting stent and a 2.50 mm x 16 mm drug eluting stent.Post-procedure, elevated cardiac enzymes were detected and the patient was diagnosed with myocardial infarction.The patient was discharged from the hospital with the continuation of aspirin and clopidogrel medications.
|
| |
|
Additional Manufacturer Narrative
|
|
E1 initial reporter facility name: (b)(6) hospital.
|
| |
|
Search Alerts/Recalls
|